CervoMed CRVO
NASDAQ CRVO
$2.97 +0.09 (+3.12%)
At close: Sep 30, 2026 · 4:00 PM EDT

CervoMed (CRVO) EV to CFO (2023)

Updated

CervoMed's EV to CFO came in at -3.01 for Q2 2023.

Analysis

CervoMed (CRVO) EV to CFO (2023) Analysis & Trends

Over the trailing twelve months to Jun 30, 2023, CervoMed reported EV to CFO of -25.06.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 CervoMed 30.43 Mn 30.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -3.01
Mar 31, 2023 -13.59
API Access

CervoMed EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=CRVO&period=max&api_key=YOUR_API_KEY